Back to Search Start Over

The impact of liver fibrosis on the progression of hepatocellular carcinoma via a hypoxia-immune-integrated prognostic model.

Authors :
Li, Qianyuan
Zhang, Junbo
Xiao, Sheng
Hu, Min
Cheng, Jie
Yao, Chenjiao
Zhuang, Quan
Source :
International Immunopharmacology. Dec2023:Part A, Vol. 125, pN.PAG-N.PAG. 1p.
Publication Year :
2023

Abstract

• A Fibrosis-Hypoxia-Glycolysis-Immune Prognostic Model (FHGISig) could significantly predict disease progression in HCC. • We revealed a close correlation between FHGISig and immune cell infiltration level as well as immune checkpoints. • TFF3 mRNA was significantly lower in cirrhotic HCC patients compared with non-cirrhotic ones. • Liver fibrosis is a poor-prognostic factor for HCC. The impact of liver fibrosis on the deterioration of hepatocellular carcinoma (HCC) remains controversial. We hope to explore this issue through establishing a fibrosis-hypoxia-glycolysis-immune related prognostic model. Liver fibrosis-related genes from Molecular Signatures Database were used to evaluate the degree of fibrosis in HCC patients from the TCGA database. The patients were divided into two groups using the fibrosis-related expression matrix based on the algorithm uniform manifold approximation and projection (UMAP) and evaluated for fibrosis by UMAP cluster and gene enrichment analysis. Prognostic model was constructed by differential analysis, LASSO, and multivariate regression analysis. Immune-infiltration analysis was performed by CIBERSORT. Quantitative PCR and immunohistochemistry were performed to measure the gene expression levels in HCC patients from our hospital. In 365 HCC patients from the TCGA database, 111 HCC patients with high fibrosis score have a worse prognosis than those with low fibrosis based on 129 genes related to liver fibrosis, which may be caused by the interaction between fibrosis, angiogenesis, hypoxia, glycolysis, inflammatory response, and high immune infiltration. We constructed a Fibrosis-Hypoxia-Glycolysis-Immune Prognostic Model (FHGISig), which could significantly predict disease progression in HCC patients. Furthermore, we revealed a close correlation between FHGISig and immune cell infiltration level as well as immune checkpoints. Finally, PCR results found TFF3 mRNA was significantly lower in cirrhotic HCC patients compared with non-cirrhotic ones. Liver fibrosis is a poor-prognostic factor for HCC, and our FHGISig could significantly predict disease progression, which could also be a potential predictive marker for immunotherapy in HCC patients. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15675769
Volume :
125
Database :
Academic Search Index
Journal :
International Immunopharmacology
Publication Type :
Academic Journal
Accession number :
173699075
Full Text :
https://doi.org/10.1016/j.intimp.2023.111136